NARNI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 17.989
EU - Europa 7.661
AS - Asia 7.038
SA - Sud America 1.039
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 174
OC - Oceania 17
Totale 34.217
Nazione #
US - Stati Uniti d'America 17.686
GB - Regno Unito 2.738
SG - Singapore 1.952
CN - Cina 1.899
IT - Italia 1.234
HK - Hong Kong 901
SE - Svezia 898
VN - Vietnam 812
BR - Brasile 751
DE - Germania 652
FI - Finlandia 463
UA - Ucraina 380
FR - Francia 344
RU - Federazione Russa 339
BD - Bangladesh 325
TR - Turchia 308
IN - India 175
KR - Corea 155
CA - Canada 152
BG - Bulgaria 136
AR - Argentina 96
ID - Indonesia 74
ES - Italia 70
MX - Messico 67
JP - Giappone 66
IQ - Iraq 62
NL - Olanda 51
EC - Ecuador 49
PL - Polonia 49
IE - Irlanda 48
BE - Belgio 45
ZA - Sudafrica 41
AE - Emirati Arabi Uniti 40
CZ - Repubblica Ceca 35
VE - Venezuela 34
CO - Colombia 33
PK - Pakistan 33
MY - Malesia 31
LT - Lituania 30
CL - Cile 28
AT - Austria 27
MA - Marocco 23
UZ - Uzbekistan 23
KE - Kenya 22
SA - Arabia Saudita 22
PH - Filippine 21
CH - Svizzera 19
EG - Egitto 19
JM - Giamaica 19
TN - Tunisia 18
RO - Romania 17
IR - Iran 16
AU - Australia 15
AZ - Azerbaigian 15
PY - Paraguay 15
BZ - Belize 12
DZ - Algeria 12
EU - Europa 12
IL - Israele 12
UY - Uruguay 12
JO - Giordania 11
PT - Portogallo 11
CR - Costa Rica 10
NP - Nepal 10
PE - Perù 10
SK - Slovacchia (Repubblica Slovacca) 10
TW - Taiwan 10
AL - Albania 9
BO - Bolivia 9
DK - Danimarca 8
ET - Etiopia 8
HN - Honduras 8
RS - Serbia 8
BH - Bahrain 7
CY - Cipro 7
GR - Grecia 7
KG - Kirghizistan 7
TH - Thailandia 7
GT - Guatemala 6
KZ - Kazakistan 6
PA - Panama 6
PS - Palestinian Territory 6
BY - Bielorussia 5
HU - Ungheria 5
NI - Nicaragua 5
DO - Repubblica Dominicana 4
LB - Libano 4
MD - Moldavia 4
MK - Macedonia 4
OM - Oman 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
EE - Estonia 3
NG - Nigeria 3
NO - Norvegia 3
SC - Seychelles 3
SI - Slovenia 3
CM - Camerun 2
Totale 33.880
Città #
Southend 2.098
Ashburn 1.712
Fairfield 1.582
Santa Clara 1.408
Singapore 1.189
Woodbridge 994
Hong Kong 886
Chandler 841
Houston 840
Ann Arbor 738
Jacksonville 715
San Jose 690
Seattle 592
Dearborn 575
Hefei 564
Wilmington 558
Nyköping 552
Cambridge 506
New York 424
Council Bluffs 392
London 333
Beijing 322
Helsinki 304
Los Angeles 302
Chicago 280
Ho Chi Minh City 258
Modena 253
Hanoi 195
The Dalles 168
San Diego 151
Seoul 149
Princeton 144
Milan 141
Izmir 134
Sofia 134
Munich 131
Eugene 128
Lauterbourg 111
Buffalo 110
Columbus 103
Salt Lake City 89
Dallas 81
Fremont 80
Bremen 71
Moscow 69
Shanghai 68
São Paulo 64
Boardman 56
Des Moines 49
Rome 49
Frankfurt am Main 48
Phoenix 48
Orem 47
Dublin 46
Jakarta 46
Tokyo 46
Bologna 45
Tampa 43
Brussels 42
Toronto 41
Elk Grove Village 40
Redwood City 39
Haiphong 38
Turku 38
Warsaw 36
Montreal 33
Atlanta 32
Da Nang 32
Brooklyn 31
San Francisco 31
Washington 31
Chennai 30
Las Vegas 27
Miami 27
Denver 26
Rio de Janeiro 25
Dong Ket 24
Miano 24
Guangzhou 23
Lancaster 23
North Bergen 23
Quito 23
Mexico City 22
Sterling 22
Nanjing 21
Brno 20
Tashkent 20
Baghdad 19
Johannesburg 19
Nairobi 19
Naples 19
Norwalk 19
Stockholm 19
Biên Hòa 18
Kunming 18
Dhaka 17
Kilburn 17
Mountain View 17
Poplar 17
Albuquerque 16
Totale 23.830
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 607
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 447
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group 440
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 427
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 414
"Biologia molecolare delle leucemie e dei linfomi: Biologia molecolare della cellula, citogenetica e genetica molecolare 394
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 388
Mucorales-specific T cells in patients with hematologic malignancies 382
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 381
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 377
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 372
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 366
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 363
Acute appendicitis in adult neutropenic patients with hematologic malignancies 361
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 357
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study 353
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 353
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 350
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 345
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 342
[The treatment of the cardiac patient in dentistry and oromaxillofacial surgery. I. The practical management of patients with arrhythmias]. Il trattamento del paziente cardiopatico in odontoiatria ed in chirurgia oro-maxillo-facciale. Nota 1: Management pratico nei pazienti portatori di turbe del ritmo. 341
Antilymphocyte globulin for prevention of chronic graft-versus-host disease 338
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: Long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect 337
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 333
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 333
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation 331
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 329
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 329
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 327
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 325
Altered expression of G1 specific genes in human malignant myeloid cells. 324
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome 324
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen 324
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study 324
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 324
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 319
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 317
Reassociation kinetics of the DNA of human acute leukemia cells. 315
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 310
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 307
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study 303
Accumulation of giant heterogeneous RNA molecules in acute myeloid leukemia blast cells. 299
T cell receptor genes expression in B cell leukaemias. 294
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 294
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 292
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 292
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 290
Bcl-2 gene expression in hematopoietic cell differentiation. 288
[Treatment of the patient with a coagulation defect in oral and maxillofacial surgery. III. The management of patients in a hypocoagulative state because of a hemophilic-type primary pathology]. Il trattamento del paziente con difetto di coagulazione in chirurgia orale e maxillo-facciale. Nota III: Il management dei pazienti in stato ipocoagulativo a causa di una patologia primaria di tipo emofilico. 287
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 287
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 286
[Management of patients with coagulation defect in oral and maxillofacial surgery. I. Management of patients with drug-induced hypocoagulation]. Il trattamento del paziente con difetto di coagulazione in chirurgia orale e maxillo-facciale. Il management dei pazienti in stato ipocoagulativo farmacoindotto. 285
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 283
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 279
KAPPA-LIGHT CHAIN GENE REARRANGEMENT IN A T-CELL LYMPHOMA 276
Leucemia linfatica cronica 274
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 271
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 268
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 266
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: Results from the EBMT NMAM2000 prospective trial 265
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 265
Study of the levels of expression of two oncogenes, c-myc and c-myb, in acute and chronic leukemias of both lymphoid and myeloid lineage.. 262
[Management of patients with coagulation disorder in oral and maxillofacial surgery. II. Management of patients with hypocoagulation caused by primary thrombocytopathy]. Il trattamento del paziente con difetto di coagulazione in chirurgia orale e maxillo-facciale. Nota II. Il management dei pazienti in stato ipocoagulativo a causa di una patologia primaria trombocitopatica. 262
In vitrocleavage of 45S pre-ribosomal RNA and of giant heterogeneous RNA extracted from human leukemic cells. 262
Human Herpes virus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction 260
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome 259
Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. 258
[The treatment of the cardiac patient in dentistry and oromaxillofacial surgery. II. The practical management of patients with hemodynamic pathologies]. Il trattamento del paziente cardiopatico in odontoiatria ed in chirurgia oro-maxillo-facciale. Nota 2: Management pratico nei portatori di patologie emodinamiche. 258
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 255
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 252
Treatment of refractory chronic GVHD with Rituximab: a GITMO study 250
Establishment and characterization of a human IgA-kappa-secreting plasma cell line (MT3). 250
Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment 249
The primary product of DNA transcription in the blast cell of acute leukemia. Its characterization as an approach to the understanding of the origin of the blast crisis of chronic myeloid leukemia 247
Philadelphia positive chronic myeloid leukemia with 22 breakpoint outside the "beakpoint cluster region" (bcr). 245
Allogeneic transplantation for multiple myeloma 244
HLA DR associated invariant chain is highly expressed in chronic lymphocytic leukemia. 241
ATYPICAL PATTERN OF LIGHT CHAIN GENE REARRANGEMENT IN HAIRY-CELL LEUKEMIA 240
Immunological assay of double-helical segments in RNA fractions of different molecular size extracted from acute myeloid leukemia blast cells. 239
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study 237
Segni sintomi e sindromi: leucocitosi, linfocitosi e linfopenie, linfoadenomegalie, splenomegalie e ipersplenismo. 232
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 231
[Management of facial pain resulting from cancer in oral and maxillofacial surgery]. Il trattamento del dolore facciale di natura oncologica in chirurgia oro-maxillo-facciale. 230
Immunoglobulin and T cell receptor beta chain gene rearrangements as lineage markers in human leukemias: a study of 78 cases. HAEMATOLOGICA 72, 391 397, 1987 228
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 228
Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it! 226
Different frequency classes of sequences in heterogeneous nuclear RNA of normal promyelocytes and lymphoblasts and of leukemic blast cells of circulating blood and of the HL60 line. 225
Bortezomib-thalidomide-dexamethasone is superior to thalidomide- dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 221
Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and sézary syndrome: A European society for blood and marrow transplantation lymphoma working party extended analysis 220
Characteristics of macromolecular RNA metabolism in leukemic promyelocytes of the HL 60 line 219
Tandem autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in myeloma – long term follow up. 218
Immunological evidence for the presence of double-stranded RNA regions in intact nuclei of normal human lymphocytes 216
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: Results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial 212
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 212
Occurrence of a novel t(11;19)(q13;q13.3) in complete remission of acute promyelocytic leukemia 211
Cytomegalovirus reactivation after hematopoietic stem cell transplant with CMV-IG prophylaxis: A monocentric retrospective analysis 207
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED FOLLICULAR LYMPHOMAS: LOW TOXICITY AND EXTENDED PROGRESSION FREE SURVIVAL. R1235 Barcelona, Spain. Bone Marrow Transplantation March 2004, Volume 33, Supplement 1 206
The effect of cytosine-arabinoside treatment on the overexpression of c-myc protooncogene in a case of prolymphocytic leukemia. 204
Molecular study of the Philadelphia translocation in chronic myelogenous leukemia in different stages of the disease. 204
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 203
Totale 29.397
Categoria #
all - tutte 128.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.156 0 0 253 171 56 117 140 153 262 175 534 295
2022/20232.541 346 319 212 243 338 325 65 216 279 25 97 76
2023/20241.773 53 81 102 135 324 302 188 242 27 31 94 194
2024/20254.885 161 53 108 315 950 718 453 247 498 188 468 726
2025/20269.875 673 412 842 1.130 1.571 684 1.159 496 954 856 677 421
2026/20271.062 270 628 164 0 0 0 0 0 0 0 0 0
Totale 34.217